236 related articles for article (PubMed ID: 19595309)
1. Sirtuins and p53.
van Leeuwen I; Lain S
Adv Cancer Res; 2009; 102():171-95. PubMed ID: 19595309
[TBL] [Abstract][Full Text] [Related]
2. SirT1 fails to affect p53-mediated biological functions.
Kamel C; Abrol M; Jardine K; He X; McBurney MW
Aging Cell; 2006 Feb; 5(1):81-8. PubMed ID: 16441846
[TBL] [Abstract][Full Text] [Related]
3. Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect.
Lara E; Mai A; Calvanese V; Altucci L; Lopez-Nieva P; Martinez-Chantar ML; Varela-Rey M; Rotili D; Nebbioso A; Ropero S; Montoya G; Oyarzabal J; Velasco S; Serrano M; Witt M; Villar-Garea A; Imhof A; Mato JM; Esteller M; Fraga MF
Oncogene; 2009 Feb; 28(6):781-91. PubMed ID: 19060927
[TBL] [Abstract][Full Text] [Related]
4. Silent information regulator 2 (SIRT1) attenuates oxidative stress-induced mesangial cell apoptosis via p53 deacetylation.
Kume S; Haneda M; Kanasaki K; Sugimoto T; Araki S; Isono M; Isshiki K; Uzu T; Kashiwagi A; Koya D
Free Radic Biol Med; 2006 Jun; 40(12):2175-82. PubMed ID: 16785031
[TBL] [Abstract][Full Text] [Related]
5. Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses.
Chen WY; Wang DH; Yen RC; Luo J; Gu W; Baylin SB
Cell; 2005 Nov; 123(3):437-48. PubMed ID: 16269335
[TBL] [Abstract][Full Text] [Related]
6. Function of the SIRT1 protein deacetylase in cancer.
Stünkel W; Peh BK; Tan YC; Nayagam VM; Wang X; Salto-Tellez M; Ni B; Entzeroth M; Wood J
Biotechnol J; 2007 Nov; 2(11):1360-8. PubMed ID: 17806102
[TBL] [Abstract][Full Text] [Related]
7. Sirtuin inhibitors.
Alcaín FJ; Villalba JM
Expert Opin Ther Pat; 2009 Mar; 19(3):283-94. PubMed ID: 19441904
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of Sirt1 by antisense oligonucleotides induces apoptosis and enhances radiation sensitization in A549 lung cancer cells.
Sun Y; Sun D; Li F; Tian L; Li C; Li L; Lin R; Wang S
Lung Cancer; 2007 Oct; 58(1):21-9. PubMed ID: 17624472
[TBL] [Abstract][Full Text] [Related]
9. Regulation of SIRT1 protein levels by nutrient availability.
Kanfi Y; Peshti V; Gozlan YM; Rathaus M; Gil R; Cohen HY
FEBS Lett; 2008 Jul; 582(16):2417-23. PubMed ID: 18544345
[TBL] [Abstract][Full Text] [Related]
10. Identification of a cell-active non-peptide sirtuin inhibitor containing N-thioacetyl lysine.
Suzuki T; Asaba T; Imai E; Tsumoto H; Nakagawa H; Miyata N
Bioorg Med Chem Lett; 2009 Oct; 19(19):5670-2. PubMed ID: 19700324
[TBL] [Abstract][Full Text] [Related]
11. SIRT1: tumor promoter or tumor suppressor?
Lim CS
Med Hypotheses; 2006; 67(2):341-4. PubMed ID: 16546327
[TBL] [Abstract][Full Text] [Related]
12. Sirt2 interacts with 14-3-3 beta/gamma and down-regulates the activity of p53.
Jin YH; Kim YJ; Kim DW; Baek KH; Kang BY; Yeo CY; Lee KY
Biochem Biophys Res Commun; 2008 Apr; 368(3):690-5. PubMed ID: 18249187
[TBL] [Abstract][Full Text] [Related]
13. Aging and anti-aging: unexpected side effects of everyday medication through sirtuin1 modulation.
Engel N; Mahlknecht U
Int J Mol Med; 2008 Feb; 21(2):223-32. PubMed ID: 18204789
[TBL] [Abstract][Full Text] [Related]
14. Acetylation of Sirt2 by p300 attenuates its deacetylase activity.
Han Y; Jin YH; Kim YJ; Kang BY; Choi HJ; Kim DW; Yeo CY; Lee KY
Biochem Biophys Res Commun; 2008 Oct; 375(4):576-80. PubMed ID: 18722353
[TBL] [Abstract][Full Text] [Related]
15. Human SIRT1: a potential biomarker for tumorigenesis?
Lim CS
Cell Biol Int; 2007 Jun; 31(6):636-7. PubMed ID: 17433727
[TBL] [Abstract][Full Text] [Related]
16. N(epsilon)-thioacetyl-lysine-containing tri-, tetra-, and pentapeptides as SIRT1 and SIRT2 inhibitors.
Kiviranta PH; Suuronen T; Wallén EA; Leppänen J; Tervonen J; Kyrylenko S; Salminen A; Poso A; Jarho EM
J Med Chem; 2009 Apr; 52(7):2153-6. PubMed ID: 19296597
[TBL] [Abstract][Full Text] [Related]
17. Aging and disease: connections to sirtuins.
Donmez G; Guarente L
Aging Cell; 2010 Apr; 9(2):285-90. PubMed ID: 20409078
[TBL] [Abstract][Full Text] [Related]
18. Sirt7 increases stress resistance of cardiomyocytes and prevents apoptosis and inflammatory cardiomyopathy in mice.
Vakhrusheva O; Smolka C; Gajawada P; Kostin S; Boettger T; Kubin T; Braun T; Bober E
Circ Res; 2008 Mar; 102(6):703-10. PubMed ID: 18239138
[TBL] [Abstract][Full Text] [Related]
19. The critical role of the class III histone deacetylase SIRT1 in cancer.
Liu T; Liu PY; Marshall GM
Cancer Res; 2009 Mar; 69(5):1702-5. PubMed ID: 19244112
[TBL] [Abstract][Full Text] [Related]
20. Study of 1,4-dihydropyridine structural scaffold: discovery of novel sirtuin activators and inhibitors.
Mai A; Valente S; Meade S; Carafa V; Tardugno M; Nebbioso A; Galmozzi A; Mitro N; De Fabiani E; Altucci L; Kazantsev A
J Med Chem; 2009 Sep; 52(17):5496-504. PubMed ID: 19663498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
